Research Technician I/II - Protein Engineering & Immunology

Benaroya Research Institute at Virginia Mason; Seattle (WA); On-site; USD 33,000 - 56,000; Full time

Benefits offered by this job

Medical, dental, vision insurance

Flexible spending accounts

Disability insurance

Life and AD&D insurance

403(b) retirement plan with matching

Job summary

Benaroya Research Institute at Virginia Mason is seeking a Research Technician I or II to lead and optimize experiments mapping antibody sequence to function. The role involves mammalian cell engineering, flow cytometry, and next-generation sequencing, with opportunities for computational biology and ML growth.

Start date anticipated November 2026, with scheduling flexibility. The successful candidate will work within a new interdisciplinary group, publish lead-author opportunities, and

Qualifications

• BS/BA in biology, bioengineering, or related field required.
• Hands-on experience in a biological research laboratory strongly preferred.
• Experience with mammalian cell culture/engineering, flow cytometry, NGS, or antibody expression is advantageous.

Responsibilities

• Execute and optimize experiments; analyze data; maintain an electronic lab notebook; prepare reagents, cell lines, plasmids, and other materials.
• Collaborate with colleagues; communicate results in meetings and presentations; contribute to building a new research laboratory.

Skills

Mammalian cell culture

Mammalian cell engineering

Flow cytometry

Next-generation sequencing

Antibody expression

Education

BS/BA in biology, bioengineering, or related field

Job description

Benaroya Research Institute at Virginia Mason is seeking a Research Technician I or II to lead and optimize experiments mapping antibody sequence to function. The role involves mammalian cell engineering, flow cytometry, and next-generation sequencing, with opportunities for computational biology and ML growth.

Start date anticipated November 2026, with scheduling flexibility. The successful candidate will work within a new interdisciplinary group, publish lead-author opportunities, and